These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 16212962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.
    Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F, Soddu S.
    Mol Cell; 2007 Mar 09; 25(5):739-50. PubMed ID: 17349959
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function.
    Di Stefano V, Blandino G, Sacchi A, Soddu S, D'Orazi G.
    Oncogene; 2004 Jul 01; 23(30):5185-92. PubMed ID: 15122315
    [Abstract] [Full Text] [Related]

  • 8. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.
    Lazzari C, Prodosmo A, Siepi F, Rinaldo C, Galli F, Gentileschi M, Bartolazzi A, Costanzo A, Sacchi A, Guerrini L, Soddu S.
    Oncogene; 2011 Dec 01; 30(48):4802-13. PubMed ID: 21602882
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V, Soddu S, Sacchi A, D'Orazi G.
    Oncogene; 2005 Aug 18; 24(35):5431-42. PubMed ID: 15897882
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
    Petroni M, Veschi V, Prodosmo A, Rinaldo C, Massimi I, Carbonari M, Dominici C, McDowell HP, Rinaldi C, Screpanti I, Frati L, Bartolazzi A, Gulino A, Soddu S, Giannini G.
    Mol Cancer Res; 2011 Jan 18; 9(1):67-77. PubMed ID: 21173028
    [Abstract] [Full Text] [Related]

  • 16. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
    Lee JH, Kim HS, Lee SJ, Kim KT.
    J Cell Sci; 2007 Jul 01; 120(Pt 13):2259-71. PubMed ID: 17591690
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
    Gynecol Oncol; 2008 Jun 01; 109(3):403-10. PubMed ID: 18395248
    [Abstract] [Full Text] [Related]

  • 19. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis.
    Di Stefano V, Rinaldo C, Sacchi A, Soddu S, D'Orazi G.
    Exp Cell Res; 2004 Feb 15; 293(2):311-20. PubMed ID: 14729469
    [Abstract] [Full Text] [Related]

  • 20. Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2.
    Muschik D, Braspenning-Wesch I, Stockfleth E, Rösl F, Hofmann TG, Nindl I.
    PLoS One; 2011 Feb 15; 6(11):e27655. PubMed ID: 22110707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.